Pharmacy Times January 19, 2022
Justin Lindhorst, MBA

Drug manufacturers participating in Medicaid offer lower prices, stretching resources and providing comprehensive services to more patients.

A recent report from the Commonwealth Fund puts the US health care system in last place compared with 11 other high-income countries.1

Despite spending the highest proportion of its gross domestic product on health care, the United States performed the worst in terms of access to care, administrative efficiency, health equity, and outcomes.1 Although the performance of the US health system affects all Americans, certain populations are at greater risk for health disparities based on their age, disability, ethnicity, gender, race, sexual identity, and socioeconomic status.2 Health disparities include, but are not limited to, differences in access to care, disease burden, life expectancy,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Insurance, Medicaid, Patient / Consumer, Pharma / Biotech, Provider, Survey / Study, Trends
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
This Biotech Startup Aims To Speed Up Drug Testing On Animals
Scientists reveal new method that could reduce waste from drug manufacturing
ETH develops AI algorithm for drug discovery based on 3D protein surface
Pharma Pulse 4/26/24: 20 States Select Direct Care Workforce Enhancement Programs by HHS, Do Assigned Roles in Clinical Trials Affect Patient-Reported Outcomes? & more

Share This Article